Cannarella Rossella, Condorelli Rosita A, Perelli Sarah, Calogero Aldo E, Greco Emanuela, Aversa Antonio, La Vignera Sandro
Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Department of Health Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
J Clin Med. 2022 Jan 28;11(3):716. doi: 10.3390/jcm11030716.
To assess whether varicocele affects testicular 25-hydroxylase activity.
Twenty normozoospermic patients with bilateral varicocele (grade III according to the Dubin and Amelar classification) without indications to undergo varicocele repair (normal sperm parameters and testicular volume; no scrotal pain) were consecutively enrolled and followed-up for four years. Serum levels of parathyroid hormone (PTH), calcium, and 25-hydroxy-cholecalciferol [25(OH)D] along with serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone (TT), conventional sperm parameters, sperm DNA fragmentation (SDF) rate, and testicular volume (TV) were measured annually for three years. PTH, calcium, and 25(OH)D serum levels over time were compared with those of age- and body mass index (BMI)-matched control group of twenty varicocelectomized patients.
Both intra- and between-group analyses showed that serum PTH levels increased significantly over time in parallel with a significant decline in 25(OH)D levels. Serum calcium levels did not change significantly. At the same time, signs of mild Leydig and Sertoli cell dysfunction were found, such as an increase in gonadotropins and decreased TT and VT. However, conventional sperm parameters and SDF rate did not change significantly.
This prospective controlled study provides the first evidence of a negative impact of bilateral grade III varicocele on testicular 25-hydroxylase activity. Accordingly, the patients included in this study showed a significant increase in PTH and a decrease in 25(OH)D levels over time. Patients with varicocele deserve endocrinologic counseling.
评估精索静脉曲张是否会影响睾丸25-羟化酶活性。
连续纳入20例双侧精索静脉曲张(根据杜宾和阿梅拉尔分类为III级)且无精索静脉曲张修复指征(精子参数和睾丸体积正常;无阴囊疼痛)的正常精子症患者,并随访4年。连续三年每年测量血清甲状旁腺激素(PTH)、钙和25-羟基胆钙化醇[25(OH)D]水平,以及血清黄体生成素(LH)、卵泡刺激素(FSH)、总睾酮(TT)、常规精子参数、精子DNA碎片率(SDF)和睾丸体积(TV)。将20例接受精索静脉结扎术患者的PTH、钙和25(OH)D血清水平随时间的变化与年龄和体重指数(BMI)匹配的对照组进行比较。
组内和组间分析均显示,血清PTH水平随时间显著升高,同时25(OH)D水平显著下降。血清钙水平无显著变化。同时,发现了轻度的Leydig细胞和Sertoli细胞功能障碍迹象,如促性腺激素增加、TT和VT降低。然而,常规精子参数和SDF率无显著变化。
这项前瞻性对照研究首次证明双侧III级精索静脉曲张对睾丸25-羟化酶活性有负面影响。因此,本研究纳入的患者随着时间的推移,PTH显著升高,25(OH)D水平降低。精索静脉曲张患者值得接受内分泌咨询。